Putnam Investments’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $32.1M | Buy |
1,069,715
+70,466
| +7% | +$2.11M | 0.04% | 169 |
|
|
2023
Q3 | $20.5M | Buy |
999,249
+202,324
| +25% | +$4.15M | 0.03% | 204 |
|
|
2023
Q2 | $15.8M | Buy |
796,925
+168,411
| +27% | +$3.35M | 0.02% | 243 |
|
|
2023
Q1 | $10.8M | Buy |
628,514
+406,514
| +183% | +$6.96M | 0.02% | 296 |
|
|
2022
Q4 | $4.34M | Buy |
+222,000
| New | +$4.34M | 0.01% | 473 |
|
|
2021
Q3 | – | Sell |
-188,698
| Closed | -$8.36M | – | 821 |
|
|
2021
Q2 | $8.36M | Hold |
188,698
| – | – | 0.01% | 413 |
|
|
2021
Q1 | $8.37M | Sell |
188,698
-143,445
| -43% | -$6.37M | 0.01% | 409 |
|
|
2020
Q4 | $18.2M | Buy |
332,143
+68,501
| +26% | +$3.76M | 0.03% | 261 |
|
|
2020
Q3 | $6.03M | Sell |
263,642
-159,995
| -38% | -$3.66M | 0.01% | 442 |
|
|
2020
Q2 | $8.87M | Buy |
423,637
+80,637
| +24% | +$1.69M | 0.02% | 355 |
|
|
2020
Q1 | $4.79M | Buy |
343,000
+136,600
| +66% | +$1.91M | 0.01% | 447 |
|
|
2019
Q4 | $4.7M | Buy |
+206,400
| New | +$4.7M | 0.01% | 519 |
|
|
2017
Q1 | – | Sell |
-8,630
| Closed | -$211K | – | 1277 |
|
|
2016
Q4 | $211K | Buy |
8,630
+112
| +1% | +$2.74K | ﹤0.01% | 1223 |
|
|
2016
Q3 | $323K | Sell |
8,518
-11,176
| -57% | -$424K | ﹤0.01% | 1172 |
|
|
2016
Q2 | $586K | Sell |
19,694
-112
| -0.6% | -$3.33K | ﹤0.01% | 1175 |
|
|
2016
Q1 | $586K | Buy |
19,806
+68
| +0.3% | +$2.01K | ﹤0.01% | 1216 |
|
|
2015
Q4 | $895K | Sell |
19,738
-751
| -4% | -$34.1K | ﹤0.01% | 1182 |
|
|
2015
Q3 | $771K | Buy |
+20,489
| New | +$771K | ﹤0.01% | 1231 |
|